Is Dr. Reddy's Laboratories stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Dr. Reddy's Laboratories pays dividends. Last time was Wednesday 28th of August 2024 where the investors holding the stock on Tuesday 16th of July 2024 were paid INR40 per share. Over the last 25 times between 2003 and 2024, Dr. Reddy's Laboratories has paid INR453 with an average of INR18.12 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Dr. Reddy's Laboratories 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR2 749.20, you would have made a profit of INR3 917.95 per share or 142.51%
Yes, the average daily trading liquidity for Dr. Reddy's Laboratories is INR443 499 thousand. You should therefore be able to get in and out of your positions relatively fast.
Dr. Reddy's Laboratories has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 2.26, the company's ability to pay off the debt is good. Dr. Reddy's Laboratories has a good net profit margin of 19.95% and should have high tolerances against inflation.
We have calculated the inflation risk for Dr. Reddy's Laboratories to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.